Viewing Study NCT04085250


Ignite Creation Date: 2025-12-24 @ 5:09 PM
Ignite Modification Date: 2026-02-25 @ 4:48 PM
Study NCT ID: NCT04085250
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-04-23
First Post: 2019-09-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Nivolumab for Non-Small Cell Lung Cancer (Stage III) Following Neoadjuvant Chemotherapy Plus Nivolumab and Definitive Concurrent Chemoradiation Therapy
Sponsor: Sun Yat-sen University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module